May 17, 2016 – Do targeted therapies diminish market volumes? Not necessarily, as we can nicely learn from the example of Nivolumab (Opdivo). While initially the targeted development of a drug (Nivolumob (Opdivo) in this case) may lead to a somewhat restricted …

Nivolumab (Opdivo): Do targeted therapies diminish market volumes of drugs? Read more »